These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3768240)

  • 41. Clinical pharmacokinetics of disopyramide.
    Siddoway LA; Woosley RL
    Clin Pharmacokinet; 1986; 11(3):214-22. PubMed ID: 3524956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha 1-acid glycoprotein.
    Eap CB; Cuendet C; Baumann P
    Clin Pharmacol Ther; 1990 Mar; 47(3):338-46. PubMed ID: 2311335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration.
    David BM; Tjokrosetio R; Ilett KF
    Ther Drug Monit; 1983; 5(1):81-6. PubMed ID: 6845403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of disopyramide in the dog. Importance of mono-N-dealkylated metabolite kinetics in assessing pharmacokinetic modeling of the parent drug.
    Cook CS; Gwilt PR; Kowalski K; Gupta S; Oppermann J; Karim A
    Drug Metab Dispos; 1990; 18(1):42-9. PubMed ID: 1970776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of disopyramide and mono-N-desisopropyl-disopyramide in serum by gas-liquid chromatography with nitrogen-selective detection.
    Brien JF; Nakatsu K; Armstrong PW
    J Pharmacol Methods; 1983 Jun; 9(4):295-308. PubMed ID: 6621050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lidocaine plasma protein binding.
    Routledge PA; Barchowsky A; Bjornsson TD; Kitchell BB; Shand DG
    Clin Pharmacol Ther; 1980 Mar; 27(3):347-51. PubMed ID: 7357791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Total and free disopyramide by fluorescence polarization immunoassay and relationship between free fraction and alpha-1 acid glycoprotein.
    Chen BH; Taylor EH; Pappas AA
    Clin Chim Acta; 1987 Feb; 163(1):75-80. PubMed ID: 3552331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of serum protein binding of felodipine.
    Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria.
    Wanwimolruk S; Denton JR
    J Pharm Pharmacol; 1992 Oct; 44(10):806-11. PubMed ID: 1360505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein.
    MacKichan JJ; Zola EM
    Br J Clin Pharmacol; 1984 Oct; 18(4):487-93. PubMed ID: 6487490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.
    Aso R; Ohashi K; Katoh T; Ogata H
    Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers.
    Echizen H; Nakura M; Saotome T; Minoura S; Ishizaki T
    Br J Clin Pharmacol; 1990 Apr; 29(4):423-30. PubMed ID: 2183867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein binding of disopyramide in liver cirrhosis and in nephrotic syndrome.
    Echizen H; Saima S; Umeda N; Ishizaki T
    Clin Pharmacol Ther; 1986 Sep; 40(3):274-80. PubMed ID: 3742934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases.
    Echizen H; Saima S; Ishizaki T
    Br J Clin Pharmacol; 1987 Aug; 24(2):199-206. PubMed ID: 3620294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticholinergic activity in the serum of patients receiving maintenance disopyramide therapy.
    Iisalo E; Aaltonen L
    Br J Clin Pharmacol; 1984 Mar; 17(3):325-9. PubMed ID: 6712865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on alpha 1-acid glycoprotein.
    Hervé F; Duché JC; d'Athis P; Marché C; Barré J; Tillement JP
    Pharmacogenetics; 1996 Oct; 6(5):403-15. PubMed ID: 8946472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison between two methods for the determination of the total and free (R)- and (S)-disopyramide in plasma using an alpha 1-acid glycoprotein column.
    Enquist M; Hermansson J
    J Chromatogr; 1989 Sep; 494():143-56. PubMed ID: 2584312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans.
    Aitio ML; Allonen H; Kanto J; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):219-26. PubMed ID: 7095921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disopyramide concentrations in saliva.
    Aitio ML; Virtanen R; Lammintausta R
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):68-72. PubMed ID: 7061181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay.
    Raghow G; Meyer MC; Straughn AB
    Ther Drug Monit; 1985; 7(4):466-71. PubMed ID: 3909539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.